Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symptom-driven ICS/LABA Therapy for Asthma Non-adherent to Daily Maintenance Inhalers
NCT05689983Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2022
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide, formoterol in asthma, sponsored by Washington University School of Medicine. Started Apr 2022; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05689983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05689983.